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A 35-year-old woman who developed whitish macules on trunk and limbs at 12 years of age and observed a remarkable increase
of the hypopigmentated lesions after her pregnancies at ages 29 and 32 years. Because of the highly characteristic clinical aspect
and the light- and electron-microscopic histopathologic ﬁndings, we diagnosed progressive macular hypomelanosis (PMH). It is a
nonscaly disorder with hypopigmented macules mainly on the trunk and is more often seen in young women. In contrast to some
authors assuming the presence of Propionibacterium spp. as a matter of principle in PMH, we report a case with no evidence for
Propionibacterium spp.
Copyright © 2009 Sven Neynaber et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Hypopigmented lesions of the skin are common and display
in general no diagnostic challenge. In Caucasians, in par-
ticular in persons with light skin type I to III according to
Fitzpatrick [1], progressive macular hypomelanosis (PMH)
is a rarely diagnosed disease posing a relevant diﬀerential
diagnosis for hypopigmentations. It is a primary, acquired
hypopigmentation ﬁrst described by Guillet et al. [2]a ﬀect-
ing mainly women 18 to 25 years of age. We here report on a
female Caucasian patient with PMH living in Germany who
observed an increase in hypopigmentation after pregnancies.
2.CaseReport
A 35-year-old woman with skin type III was referred to our
department for the evaluation of whitish macules on trunk
and limbs. They ﬁrst appeared when she was 12 years old
and increased slowly but steadily in size and number. After
the ﬁrst gravidity at age 29 and a second one at age 32
the patient observed a marked acceleration of this process.
There is no history of itching or dysaesthesia. The patient
deniedrecreationalsunexposureforthepasttenyears.When
she was exposed to sunlight the whitish macules did not
changethecolourwhereasthenonaﬀectedskinbecamemore
tanned, so that the contrast between the whitish macules and
the nonaﬀected skin was remarkably intensiﬁed. She had not
been on antibiotics, birth-control or hormone, containing
pills, had no noteworthy history of dermatitis or eczema.
Signs of atopy were absent. Her ancestors lived for many
generations in Germany.
Skin ﬁndings consist of symmetrically distributed
hypopigmented, nummular, partial conﬂuent, nonscaly
macules on trunk and less pronounced on proximal parts of
arms and legs, as well as sparing head and neck (Figures 1(a),
1(b)). Distribution is neither segmental nor does it follow
Blaschko-lines. The round or oval hypopigmentated macules
have well-deﬁned borders. No signs of inﬂammation are
present in these macules. Uninvolved skin displays brownish
coloration alike typical skin type III.
There was no evidence for fungi or other infectious
agents in morphologic and cultural surveys on repeated
attempts. A Biopsy from aﬀected skin displayed a reduced
amount of melanin in the basal layer compared to nonaf-
fected skin.
Upon electron microscopic comparison of type and
distribution patterns of melanosomes in aﬀected (Figure 3)
and nonaﬀected epidermis (Figure 2), we found those
in macules of PMH to be more aggregated and single
melanosomes were smaller. They displayed ﬁlaments and
looked tessellated (stage I-II). In contrast the melanosomes
in nonaﬀected skin are usually larger and distributed2 Dermatology Research and Practice
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Figure 1: (a) Disseminated whitish macules on the front and the back of the trunk. (b) Nonscaly macules in detail on the back.
(a) (b)
Figure 2: Electron microscopy of non-aﬀected skin. Left (8:300×): numerous melanosomes aggregated in big clusters and disseminated
melanosomes. Right detail (49:800×): Granular melanosomes mostly grade III-IV.
more evenly with less discernible internal structures. In
other words the aﬀected skin is characterized by less
developed melanosomes (stage I or II), whereas non-
aﬀected epidermis displays mature melanosomes (stage
III or IV) according to the natural skin type of the
patient.
3. Discussion
PMH was ﬁrst published by Guillet et al. in 1988 [2].
He described a disorder prevalent in young women (aged
13 to 35 years) in the West Indies and in a Caribbean
immigrant population in France characterized by spreading
hypochromic macules on the trunk. The condition appears
mainly in persons of mixed genetic background [3]w i t h
round, pale, coalescent macules on the back and less
frequently on the abdomen. A larger study performed in
Martinique revealed the condition to be more widespread in
m e nt h a ni nw o m e n ,w i t ham e a na g eo f2 5y e a r s[ 4]. PMH
is until recently thought to be an idiopathic disease wich
is rarely seen in middle and northern Europe, being much
more frequently reported from countries with a multiethnic
population of skin type IV–VI [1]. This case seems to be the
ﬁrst reported patient with PMH in Germany. Recently Di
Lernia et al. [5] reported ﬁve patients in Italy of skin type
IV-V, three of them of Caucasian one of North-African, and
one of Afro-Caribbean origin, respectively. Kumarasinghe et
al. [6] reported on eight Chinese patients with PMH.
Several diﬀe r e n t i a l sh a v et ob er u l e do u to n c eP M Hi s
considered: Pityriasis alba is a benign condition in children
and adolescents, which is frequently located on the face pre-
senting a hypopigmentation with ﬁne pityriasiform scaling.
Postinﬂammatory hypopigmentation is usually more local-
ized than PMH and occurs in the aftermath of inﬂammatory
conditions such as lichen planus or eczema as irregularlly
shaped lesions. Idiopathic guttate hypomelanosis is known
as a disorder of both sexes going along with multiple
tiny confetti-like hypopigmented macules on extremities,
especially on calves and shins, representing, therefore, the
closest diﬀerential diagnosis to PMH.
In general PMH does not respond well to antifungal
or antieczematous therapy. A recent study of 45 patients
with intraperson comparison of two treatment strategies—
5% benzoyl peroxide hydrogel/1% clindamycin lotion in
combination with UVA irradiation versus 0.05% ﬂuticasone
propionate cream in combination with UVA irradiation—
found the antibacterial treatment superior (photometric
measurements P = .007, patient assessment P<. 0001,
and dermatologist assessment P<. 0001) [7]. PUVA und
UVB therapy was reported to achieve improvement [8], at
least transiently in a few cases. Anyhow, sometimes the PMH
regresses spontaneously within a few years.Dermatology Research and Practice 3
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Figure 3:Electronmicroscopyofaﬀectedskin.Left(8:300×):sparsemelanosomesaggregatedinsmallclustersandsomesolitary.Rightdetail
(49:800×): Melanosomes mostly grade I-II, few grade III and less granular.
A cosmetic concern is frequently the reason for con-
sultation of a dermatologist because the young women feel
cosmetically deprived with in times psychological repercus-
sions. Authors around the globe used terms like cutis trunci
variata [9], creole dyschromia [4], idiopathic multiple large-
macule hypomelanosis [10], and nummular and conﬂuent
hypomelanosis of the trunk describing similar symptoms as
in PMH.
In our patient we did not ﬁnd an evidence for fungi,
neither in cyanoacrylate surface skin biopsies nor morpho-
logically in KOH preparations of scrapings, nor in culture,
nor histologically in the biopsy. These negative mycological
investigations support the ﬁndings from Westerhof et al.
[11] and Guillet et al. [4] that fungi are not likely causal to
PMH.
Relyveld et al. postulate that diﬀerent subtypes of Pro-
pionibacterium species cause the appearance of PMH [12].
But species of Propionibacteria c a nb ef o u n da l lo v e rt h e
body and are generally nonpathogenic. To the best of our
knowledge there is no further evidence in the English and
German literature available in support of a pathogenic role
of P. acnes ssp. in hypopigmentation. This ﬁnding has to be
veriﬁed independently in the future. On multiple attempts
we did not ﬁnd any evidence for this pathogen in this
patient, neither clinical with Wood’s light, nor histological
in special stains (Gram, Giemsa). Therefore we question the
causality of Propionibacteria in PMH, as, for example, many
patients suﬀering of acne do have massive Propionibacteria
colonisation and do not show hypopigmentation as in PMH,
nor is hypopigmentation on face and other aﬀected areas a
typical feature in these patients.
With electron microscopy investigations we conﬁrmed a
distinct change in the maturation, number, and distribution
of the melanosomes in the aﬀected skin. Theses results are
consistent with those of Relyveld et al. [12, 13], although
PMHismoreoftendiagnosedinskintypeIV-Vwithelectron
microscopy ﬁndings beeing more distinctive.
The accelerated progression of hypopigmentation ob-
served here during pregnancy could suggest that hormones
may play a pathogenetic role albeit serological misbalance of
hormones was not found during gestation. There are many
skindisordersknowntobeworsenedthroughpregnancyand
it could be the same with PMH. Another clue to hormonal
inﬂuence is that all aﬀected patients in literature were in
a reproductive age, whereas the putative gynecotropism
could be not solely due to a result of bias in reporting
[6], but valid epidemiologic data are not available [6]. In
consequence, PMH is a rarely reported entity in Europe
whose aetiology still remains an enigma. The clinical course
is unpredictable, but spontaneous resolution can occur
within years or decades.
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